Furthermore, our study showed that the combination of Romo1 inhibition and PD-1 blockade significantly improved the survival outcome of glioblastoma in mouse model, implicating that Romo1 may have an important role in regulating the crosstalk between tumor-associated macrophages and T cells. The gene discussed is ROMO1; the disease is neoplasm.